Ichiro Yabe

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Effects of Extracranial–Intracranial Bypass for Patients With Hemorrhagic Moyamoya Disease

Susumu Miyamoto, Takashi Yoshimoto, Nobuo Hashimoto et al. · Stroke · 2014 · 616 citations · Full text

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 187 citations

Jasmitt Study, Clinical Injury, Neurological Disorder +10

Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese

Toshiyuki Fukazawa, Ichiro Yabe, Seiji Kikuchi et al. · Journal of the Neurological Sciences · 1999 · 177 citations

Disease Susceptibility, Autoimmune Disease, Neurological Disorder +9

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Sonoko Misawa, Satoshi Kuwabara, Yasunori Sato et al. · The Lancet Neurology · 2018 · 159 citations

Medicine, Neurology, Guillain-barré Syndrome +1